טוען...
Development of therapeutic agents for elderly patients with acute myelogenous leukemia
Acute myelogenous leukemia (AML) is a disease more common in the elderly than the young. It is increasingly recognized that conventional cytotoxic chemotherapies used in children and young adults may not be appropriate in older adults because of diverse host- and disease-biology factors. This review...
שמור ב:
| הוצא לאור ב: | Curr Opin Investig Drugs |
|---|---|
| Main Authors: | , |
| פורמט: | Artigo |
| שפה: | Inglês |
| יצא לאור: |
2010
|
| נושאים: | |
| גישה מקוונת: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4699173/ https://ncbi.nlm.nih.gov/pubmed/20496262 |
| תגים: |
הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|